Guidant v. Medtronic
This article was originally published in The Gray Sheet
Executive Summary
Delaware federal court jury affirms that Medtronic Driver and S7 coronary stents infringe Guidant's Lau patents, and that the patents are valid. The move is in-line with a Jan. 5 ruling and overturns a subsequent reversal (1"The Gray Sheet" Jan. 10, 2005, p. 3). Medtronic says its next step will be to pursue an unenforceability claim for "inequitable conduct," and that the current findings do not affect U.S. sales of the devices...